CD155 has been shown to be highly expressed in melanoma cells [154], and the overexpression of CD155 in cancer cells induces DNAM-1 internalised in NK cells, resulting in reduced NK cell activity [155] (Figure 2). The gene discussed is PVR; the disease is cancer.